DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Details Narrative) - USD ($)	1 Months Ended										3 Months Ended		12 Months Ended
	Feb. 29, 2024	Jan. 31, 2024	Oct. 31, 2023	Jul. 31, 2023	Feb. 28, 2023	Jun. 30, 2022	Dec. 31, 2021	Nov. 30, 2021	Sep. 30, 2021	May 31, 2021	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023	Dec. 31, 2022	May 31, 2022	Mar. 31, 2022	Feb. 28, 2022	Jan. 31, 2022	Aug. 31, 2021	Jun. 30, 2020
Conversion fee, values	$ 35,000
Warrants issued to purchase shares											33,000,000
Warrants issuance cost														$ 2,900,000
Purchase of warrants											31,890,289
Common stock, par value											$ 0.01		$ 0.01
Conversion fee, shares	500,000
Net Income (Loss) Attributable to Parent											$ (408,676)	$ (525,419)
Working capital deficit											16,300,000
Net cash used in operating activities											200,000
Autotelic Inc [Member]
Proceeds from related party											$ 250,000
Oncotelic Warrant [Member]
Warrants issued to purchase shares																	33,000,000
Purchase of common stock, value																	$ 50,000
Warrant [Member]
Purchase of warrants											33,000,000
Common Stock [Member]
Conversion fee, values	$ 35,000				$ 71,750						$ 35,000
Conversion fee, shares	500,000				1,025,000						500,000
Biomedical Advanced Research and Development Authority [Member]
Investment company, general partner advisory service											$ 750,000
Supplemental Agreement [Member] | Golden Mountain Partners LLC [Member]
Investment company, grant amount											$ 1,200,000
JH Darbie Placement Agreement [Member]
Debt conversion description				Subsequently, the Company paid JH Darbie an advance of $75,000 for processing the first tranche of the Financing and the balance of their fees of $75,000 in July 2023, when the Financing for both Tranche 1 and Tranche 2 was closed. The issuance of the Units in July 2023 represented the two tranches of the Financing (“Tranche 1 and 2”). Based on the placement agent agreement, JH Darbie was entitled to a non-refundable $25,000 fee to start the due diligence process and 2% due diligence fees and 13% commissions on all subsequent conversions or new funding. In addition, the Company is to provide warrant coverage equal to 13 % of all of the units sold to JH Darbie. As the Company converted an aggregate of 40 units, JH Darbie was entitled to earn a total of 1,300,000 warrants. Further, in October 2023, the Company entered into a series of subscription agreements with 27 accredited investors which resulted in a conversion of a gross amount of $1.05 million, consisting of 42 notes, under the prior JH Darbie Financing into new debt to the Company. As the Company converted an aggregate of 42 units, JH Darbie was entitled to earn a total of 1,365,000 warrants. This conversion constituted to be Tranche 3 of the July 2023 PPM and the terms and conditions of such conversion are the same as that of the first 2 Tranches. In January 2024, the Company entered into a series of subscription agreements with 4 accredited investors which resulted in a conversion of a gross amount of $0.3 million, consisting of 12 notes, under the prior JH Darbie Financing into new debt to the Company. As the Company converted an aggregate of 12 units, JH Darbie was entitled to earn a total of 390,000 warrants.
JH Darbie Placement Agreement [Member] | Warrant [Member]
Number of shares issued			250,000	250,000
JH Darbie Placement Agreement [Member] | Accredited Investors [Member]
Conversion fee, values		$ 1,000,000.0	$ 1,050,000.00	$ 1,000,000.0
Debt conversion description		JH Darbie and the Company are parties to a March 2023 placement agent agreement (“Agreement”) pursuant to which JH Darbie has the right to sell/convert a minimum of 10 Units and a maximum of 200 Units on a best-efforts basis		JH Darbie and the Company are parties to a March 2023 placement agent agreement (“Agreement”) pursuant to which JH Darbie has the right to sell/convert a minimum of 10 Units and a maximum of 200 Units on a best-efforts basis
JH Darbie Placement Agreement [Member] | Additionally Accredited Investors [Member]
Conversion fee, values		$ 300,000
Equity Purchase Agreement [Member] | Peak One Opportunity Fund, L.P [Member]
Common shares issued for cash										$ 10,000,000.0
Common stock, par value										$ 0.01
Note Purchase Agreements [Member] | Autotelic Inc [Member]
Debt instrument face amount																			$ 698,500
Debt instrumental interest rate																			5.00%
Securities Purchase Agreements [Member]
Common stock, par value							$ 0.01	$ 0.01
Debt instrument face amount							$ 250,000	$ 250,000							$ 600,000	$ 250,000
Proceeds from convertible debt							$ 1,250,000	$ 1,250,000
Number of shares issued						4,025,000
Securities Purchase Agreement [Member]
Debt instrument face amount						$ 340,000
Debt instrumental interest rate											25.00%
Securities Purchase Agreement [Member] | Fourth Man LLC [Member]
Convertible debt													$ 127,000
Conversion fee, shares											1,820,395
Securities Purchase Agreement and Purchase Agreement [Member] | Golden Mountain Partners [Member]
Debt instrument face amount																		$ 4,500,000		$ 4,500,000
License Agreement [Member]
Milestone payment									$ 50,000,000
Royalties percent											15.00%
Since Inception Date [Member]
Net Income (Loss) Attributable to Parent													$ 34,000,000
Point R merger agreement [Member]
Working capital deficit											$ 2,600,000